Table 2 Comparison through the treatment groups of the variables considered in the study (FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; PRI, pain rating index)
Variables | Control | Experimental | Placebo | |
|---|---|---|---|---|
(n = 37) | (n = 35) | (n = 37) | ||
Gender | Men | 32.3% (21) | 38.5% (25) | 29.2% (19) |
Women | 36.4% (16) | 22.7% (10) | 40.9% (18) | |
Age | 66.27 (10.55)c | 64.86 (12.14) | 65.62 (10.93) | |
PRI total | Initial (post Qx) | 30.59 (8.96) | 25.71 (12.42) | 26.92 (11.12) |
Final | 28.35 (7.61)*§ | 11.69 (7.53)* | 22.86 (9.33)* | |
FVC | Initial (post Qx) | 51.81 (11.14) | 56.66 (8.54) | 59.83 (11.14) |
Final | 59.68 (9.72)* | 83.77 (14.04)* | 69.11 (12.07)* | |
FEV1 | Initial (post Qx) | 55.00 (11.12) | 58.37 (9.72) | 63.54 (14.14) |
Final | 61.54 (9.56) * | 87.06 (13.41)* | 71.46(11.40)* | |